Respiratory Care Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Therapeutic Devices, Monitoring Devices, Consumables, Accessories), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 18.92 Billion
CAGR (2026-2031)	8.62%
Fastest Growing Segment	Monitoring Devices
Largest Market	North America
Market Size (2031)	USD 31.07 Billion

Market Overview

The Global Respiratory Care Devices Market will grow from USD 18.92 Billion in 2025 to USD 31.07 Billion by 2031 at a 8.62% CAGR. Respiratory care devices encompass a broad category of medical equipment designed for the diagnosis, monitoring, and treatment of cardiopulmonary diseases. The expansion of this sector is fundamentally driven by the escalating global prevalence of chronic conditions such as asthma and chronic obstructive pulmonary disease which necessitates consistent therapeutic intervention. According to the American Lung Association, in 2024, nearly 131 million people in the United States lived in areas with unhealthy levels of air pollution. This environmental factor significantly exacerbates lung health issues and reinforces the sustained demand for supplemental oxygen systems and bronchial hygiene devices.

A significant challenge impeding market growth is the high acquisition cost associated with advanced ventilation and monitoring technologies. Budgetary constraints in healthcare systems across developing nations often restrict the procurement of these essential apparatuses and limit patient access to necessary treatments. Additionally, inconsistent reimbursement policies for home-care respiratory settings create financial uncertainty for providers and patients alike which can stall the broader adoption of newer therapeutic modalities in price-sensitive regions.

Key Market Drivers

The escalating global prevalence of chronic and infectious respiratory diseases serves as the foremost driver propelling the respiratory care devices market. As airborne pathogens and pollutants compromise lung function globally, the necessity for consistent therapeutic and diagnostic interventions has intensified, particularly for conditions requiring long-term management. This rising disease burden compels healthcare systems to expand their inventories of airway management and oxygen therapy systems to handle the influx of patients needing critical respiratory support. According to the World Health Organization, October 2024, in the 'Global Tuberculosis Report 2024', an estimated 10.8 million people fell ill with tuberculosis worldwide in 2023, a statistic that underscores the critical need for robust deployment of respiratory support mechanisms in high-burden regions.

Concurrently, there is a substantial surge in demand for home-based respiratory care and remote monitoring solutions, fundamentally reshaping service delivery. Patients and providers are increasingly favoring portable, smart devices that facilitate continuous therapy outside traditional hospital settings, driven by the objective to reduce hospital readmission rates and enhance patient quality of life. This structural shift toward domicile-focused treatment is evident in the financial performance of major industry players prioritizing residential solutions. According to Fisher & Paykel Healthcare, May 2024, in the 'Annual Report 2024', revenue for the Homecare product group increased 18% to $652.3 million, highlighting the rapid adoption of home-use technologies. Reflecting the broader sector's expansion, according to ResMed, in 2024, quarterly revenue increased by 9% to reach $1.2 billion, demonstrating the sustained financial investment in advanced respiratory care ecosystems.

Download Free Sample Report

Key Market Challenges

The high acquisition cost associated with advanced ventilation and monitoring technologies constitutes a primary obstacle impeding the growth of the global respiratory care devices market. This financial barrier significantly restricts the procurement of essential medical equipment, particularly in developing nations where healthcare infrastructure faces severe funding limitations. Consequently, the inability to afford these critical apparatuses limits patient access to necessary treatments and slows the broader adoption of newer therapeutic modalities in price-sensitive regions.

Moreover, the sheer economic burden of respiratory diseases further strains healthcare budgets, leaving limited resources for investing in expensive device upgrades. According to the European Respiratory Society, in 2024, the societal cost of lung health in the European Union reached €422 billion annually. This substantial financial load creates uncertainty for providers and complicates the reimbursement landscape, making it difficult for facilities to prioritize capital expenditure on high-cost respiratory systems. As a result, the market experiences stalled expansion in key territories as healthcare systems struggle to balance the rising costs of disease management with the need for advanced technological solutions.

Key Market Trends

The Adoption of AI and Machine Learning for Predictive Diagnostics is rapidly advancing within the respiratory sector, driven by substantial capital infusion into technologies that automate the interpretation of lung imaging and respiratory biometrics. This trend is characterized by the development of sophisticated algorithms capable of identifying early-stage malignancies and tuberculosis with greater accuracy than traditional manual review, thereby attracting significant investor confidence in their potential to transform clinical outcomes. Highlighting this financial momentum, according to Qure.ai, September 2024, in the 'Press Release: Qure.ai Raises $65 Million in Series D Funding', the company secured $65 million to accelerate the expansion of its AI-powered lung health solutions into the US market, confirming the high industry stake in automated diagnostic capabilities.

Simultaneously, the Integration of Smart Connectivity and IoT in Respiratory Devices is reshaping the market by establishing interoperable care ecosystems that link hardware directly to clinical oversight platforms. Manufacturers are increasingly embedding high-fidelity data transmission modules into ventilators and patient monitors to allow for the continuous and remote visualization of respiratory mechanics which significantly improves hospital workflow and patient safety. This strategic emphasis on networked solutions is validated by recent financial results; according to Royal Philips, February 2024, in the 'Annual Report 2023', comparable sales for the Connected Care business segment increased by 5% which was fueled by double-digit expansion in their hospital patient monitoring portfolio, demonstrating the critical demand for integrated respiratory informatics.

Segmental Insights

The Monitoring Devices segment is anticipated to emerge as the fastest growing category within the Global Respiratory Care Devices Market. This expansion is primarily driven by the rising prevalence of chronic respiratory conditions such as COPD and asthma which necessitate continuous patient assessment to prevent complications. Furthermore, the transition towards home-based healthcare has accelerated the demand for user-friendly pulse oximeters and capnography systems. Regulatory bodies such as the US Food and Drug Administration have supported this trajectory by clearing devices that facilitate early detection of respiratory distress, thereby improving long-term patient management and reducing hospital readmission rates.

Regional Insights

North America holds a dominant position in the Global Respiratory Care Devices Market, primarily driven by the high prevalence of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This leadership is supported by a robust healthcare infrastructure that facilitates widespread access to advanced therapeutic and diagnostic equipment. Furthermore, the region benefits from a well-defined regulatory environment, where the U.S. Food and Drug Administration (FDA) plays a critical role in establishing safety standards and streamlining product approvals. The strong presence of major medical device manufacturers investing in research and development further consolidates North America's market stability and growth.

Recent Developments

• In December 2025, SleepRes, Inc. obtained FDA 510(k) clearance for its Kricket PAP device, a new therapeutic solution for obstructive sleep apnea. The device featured the company’s proprietary Kairos Positive Airway Pressure technology, which was designed to dynamically adjust air pressure in synchronization with a patient's natural breathing cycle. This adaptive approach aimed to enhance user comfort and adherence by reducing unnecessary pressure during exhalation compared to traditional continuous positive airway pressure machines. The company announced that the system was cleared for use in home and clinical settings for patients weighing more than 66 pounds.
• In September 2025, Masimo and Royal Philips announced a multi-year expansion of their strategic partnership to integrate advanced monitoring technologies into a broader range of patient care devices. The collaboration focused on embedding Masimo’s Signal Extraction Technology pulse oximetry and wearable sensor capabilities into Philips’ multi-parameter patient monitors and central stations. This agreement aimed to improve interoperability and data continuity across the entire care continuum, from the hospital bedside to remote home monitoring. Both companies stated they would also co-develop next-generation AI-based monitoring tools to support clinical decision-making.
• In September 2024, ResMed announced the launch of the AirTouch N30i, distinguishing it as the company's first fabric-wrapped nasal CPAP mask. The device featured a soft, breathable frame with a tube-up design intended to provide a more natural and comfortable sleep experience for patients treating sleep apnea. The Chief Product Officer of ResMed noted that the mask was engineered to address common adherence barriers by prioritizing comfort and visual appeal without compromising the stability of the seal. The product was introduced to the market to offer a less clinical aesthetic and improve long-term therapy compliance.
• In August 2024, Fisher & Paykel Healthcare launched the F&P my820 System in the United States, a respiratory humidifier specifically designed for home mechanical ventilation. The system was engineered to provide heated humidification for patients requiring invasive ventilation, noninvasive ventilation, or high-flow therapies. It featured an integrated sensor that automatically adapted to environmental temperature fluctuations to minimize circuit condensation and simplify the setup process for users. The company highlighted that this release represented a significant investment in technologies aimed at improving clinical outcomes and care quality for patients managing respiratory conditions at home.

Key Market Players

• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• General Electric Company
• Getinge AB
• Inogen, Inc.
• Masimo
• Medtronic
• Koninklijke Philips N.V.
• ResMed
• VYAIRE

By Product	By End User	By Region
Therapeutic Devices Monitoring Devices Consumables Accessories	Hospitals & Clinics Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Respiratory Care Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Respiratory Care Devices Market, By Product:

• Therapeutic Devices
• Monitoring Devices
• Consumables
• Accessories

• Respiratory Care Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

• Respiratory Care Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE